From 2012 through 2015, of the 12.7 million ambulatory visits at which buprenorphine was prescribed, 94.8% of the prescriptions were for White people, 2.7% were for Black people, and 2.4% for those of other races or ethnicities. From 2004 to 2015, buprenorphine was prescribed at 13.4 million visits, representing about 0.36% of all ambulatory visits during that period. For other outpatient visits (no buprenorphine prescribed), 83.1% were for White people, 10.6% were for Black people, and 6.3% were for people of other races and ethnicities. From 2012 through 2015, the odds . . .